ALAN LEWIS Insider Trading $BMRN BIOMARIN PHARMACEUTICAL INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ALAN LEWIS.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ALAN LEWIS. ALAN LEWIS is Director in BIOMARIN PHARMACEUTICAL INC ($BMRN).

ALAN LEWIS in BIOMARIN PHARMACEUTICAL INC

Trading Symbol: BMRN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ALAN LEWIS: Director
Holdings: 21,400 shares
Current Value: $1,902,674
Latest Transaction: Dec 08 2014
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of ALAN LEWIS in BIOMARIN PHARMACEUTICAL INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Dec 08 2014BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseM21.517,500161,3250
Dec 08 2014BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS89.907,500674,22521,40028.9 K to 21.4 K (-25.95 %)
Dec 08 2014BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorBuyM21.517,500161,32528,90021.4 K to 28.9 K (+35.05 %)
Jun 06 2014BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA63.106,600416,4606,600
Jun 06 2014BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorGrantA0.002,100021,40019.3 K to 21.4 K (+10.88 %)
Dec 11 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseM38.597,500289,4250
Dec 11 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseM26.4915,000397,3500
Dec 11 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS69.9122,5001,572,98219,30041.8 K to 19.3 K (-53.83 %)
Dec 11 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorBuyM38.597,500289,42541,80034.3 K to 41.8 K (+21.87 %)
Dec 11 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorBuyM26.4915,000397,35034,30019.3 K to 34.3 K (+77.72 %)
May 17 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA67.818,500576,3858,500
May 17 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorGrantA0.003,400019,30015.9 K to 19.3 K (+21.38 %)
May 17 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA67.818,500576,3858,500
May 17 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorGrantA0.003,400019,30015.9 K to 19.3 K (+21.38 %)
Feb 28 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseM21.517,500161,32546,000
Feb 28 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseM14.397,500107,92553,500
Feb 28 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseM38.597,500289,42561,000
Feb 28 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS56.5722,5001,272,76215,90038.4 K to 15.9 K (-58.59 %)
Feb 28 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorBuyM21.517,500161,32538,40030.9 K to 38.4 K (+24.27 %)
Feb 28 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorBuyM14.397,500107,92530,90023.4 K to 30.9 K (+32.05 %)
Feb 28 2013BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorBuyM38.597,500289,42523,40015.9 K to 23.4 K (+47.17 %)
Nov 09 2012BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseM17.3315,000259,95068,500
Nov 09 2012BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS46.8015,000702,00015,90030.9 K to 15.9 K (-48.54 %)
Nov 09 2012BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorBuyM17.3315,000259,95030,90015.9 K to 30.9 K (+94.34 %)
Aug 06 2012BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseM14.2130,000426,30083,500
Aug 06 2012BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS37.5740,0001,502,75615,90055.9 K to 15.9 K (-71.56 %)
Aug 06 2012BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorBuyM14.2130,000426,30055,90025.9 K to 55.9 K (+115.83 %)
May 10 2012BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA37.468,500318,410113,500
May 10 2012BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorGrantA0.003,400025,90022.5 K to 25.9 K (+15.11 %)
May 16 2011BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA26.4915,000397,350105,000
May 16 2011BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorGrantA0.002,500022,50020 K to 22.5 K (+12.50 %)
May 14 2010BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA21.5115,000322,65090,000
May 14 2010BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorGrantA0.002,500020,00017.5 K to 20 K (+14.29 %)
May 27 2009BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA0.002,50000
May 27 2009BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorGrantA0.002,500017,50015 K to 17.5 K (+16.67 %)
May 14 2009BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA14.3915,000215,85075,000
May 14 2009BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorGrantA0.002,500015,00012.5 K to 15 K (+20.00 %)
Jul 08 2008BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA0.002,50002,500
Jul 08 2008BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorGrantA0.002,500012,50010 K to 12.5 K (+25.00 %)
May 27 2008BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA0.002,50005,000
May 27 2008BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA38.5915,000578,85060,000
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseM7.7230,000231,60045,000
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.254008,10010,00010.4 K to 10 K (-3.85 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.008,300166,00010,40018.7 K to 10.4 K (-44.39 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.012004,00218,70018.9 K to 18.7 K (-1.06 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.032004,00618,90019.1 K to 18.9 K (-1.05 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.071,60032,11219,10020.7 K to 19.1 K (-7.73 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.082004,01620,70020.9 K to 20.7 K (-0.96 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.091,00020,09020,90021.9 K to 20.9 K (-4.57 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.112004,02221,90022.1 K to 21.9 K (-0.90 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.122004,02422,10022.3 K to 22.1 K (-0.90 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.131,60032,20822,30023.9 K to 22.3 K (-6.69 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.1480016,11223,90024.7 K to 23.9 K (-3.24 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.1560012,09024,70025.3 K to 24.7 K (-2.37 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.161,00020,16025,30026.3 K to 25.3 K (-3.80 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.1760012,10226,30026.9 K to 26.3 K (-2.23 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.181,50030,27026,90028.4 K to 26.9 K (-5.28 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.191,10022,20928,40029.5 K to 28.4 K (-3.73 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.213006,06329,50029.8 K to 29.5 K (-1.01 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.231002,02329,80029.9 K to 29.8 K (-0.33 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorSellS20.241002,02429,90030 K to 29.9 K (-0.33 %)
Aug 14 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorBuyM7.7230,000231,60030,0000 to 30 K
Jun 11 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA0.002,50002,500
Jun 11 2007BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA17.3315,000259,95075,000
Aug 17 2006BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA14.2130,000426,30060,000
Jul 06 2005BMRNBIOMARIN PHARMACEU ...LEWIS ALANDirectorOption ExerciseA7.7230,000231,60030,000

Page:   1